首页> 外文OA文献 >PGI10 IS THE INTRODUCTION OF REFERENCE BASED PRICING FOR PATENT PROTECTED DRUGS A COST-SAVING OPTION FOR HEALTH CARE?

【2h】

PGI10 IS THE INTRODUCTION OF REFERENCE BASED PRICING FOR PATENT PROTECTED DRUGS A COST-SAVING OPTION FOR HEALTH CARE?

机译：PGI10为受专利保护的药物引入基于参考的定价是一种节省医疗费用的选择吗？

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Kulp W; Greiner W; Schulenburg JM;
展开▼
作者单位

展开▼
年度 2005
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. The importance of measuring strength-of-preference scores for health care options in preference-sensitive care [J] . CrumpR.T., Llewellyn-ThomasH.A. Journal of Clinical Epidemiology . 2012,第8期

机译：在偏好敏感型医疗保健中，衡量医疗保健选择偏好强度得分的重要性
2. Value-Based Pricing and Reimbursement in Personalised Healthcare: Introduction to the Basic Health Economics [J] . Louis P. Garrison, Adrian Towse Journal of Personalized Medicine . 2017,第3期

机译：个性化医疗保健中基于价值的定价和报销：基本卫生经济学简介
3. The impact of Medicare Part D on out-of-pocket costs for prescription drugs, medication utilization, health resource utilization, and preference-based health utility. [J] . Liu FX, Alexander GC, Crawford SY, Health services research: HSR . 2011,第4期

机译：Medicare D部分对处方药的自付费用，药物利用，健康资源利用和基于偏爱的健康效用的影响。
4. A Real Option Based Model for the Valuation of Patent Protected Technological Innovation Projects [C] . Daniel Hernandez-Garcia, David Guemes-Castorena, Idalia Ponce Jaramillo Portland International Conference on Management of Engineering and Technology . 2017

机译：基于实物期权的专利保护技术创新项目评估模型
5. The Drug Price Competition and Patent Term Restoration Act of 1984 and ethical brand name drug pricing behavior. [D] . Strauss, Bonnie Meyer. 1995

机译：1984年《药品价格竞争和专利期限恢复法案》以及道德的品牌名称药品定价行为。
6. Off-Patent Generic Medicines vs. Off-Patent Brand Medicines for Six Reference Drugs: A Retrospective Claims Data Study from Five Local Healthcare Units in the Lombardy Region of Italy [O] . Giorgio L. Colombo, Enrico Agabiti-Rosei, Alberto Margonato, -1

机译：六种参考药物的非专利仿制药与非专利品牌药物：来自意大利伦巴第大区五个本地医疗单位的回顾性索赔数据研究
7. Off-patent generic medicines vs. off-patent brand medicines for six reference drugs: a retrospective claims data study from five local healthcare units in the Lombardy Region of Italy. [O] . Giorgio L Colombo, Enrico Agabiti-Rosei, Alberto Margonato, 2013

机译：六种参考药物的非专利仿制药与非专利品牌药：来自意大利伦巴第大区五家当地医疗保健单位的回顾性索赔数据研究。

PGI10 IS THE INTRODUCTION OF REFERENCE BASED PRICING FOR PATENT PROTECTED DRUGS A COST-SAVING OPTION FOR HEALTH CARE?

著录项

引文网络

相似文献

相关主题

期刊订阅